GENE ONLINE|News &
Opinion
Blog

Everest Medicines
South Korea Puts Everest Medicines’ Nefecon On Fast Track
2023-02-10
Everest, Calliditas Win First Approval for Rare Kidney Disease Drug in Europe
2022-07-18
Everest Medicines Secures Breast Cancer Drug Approval in China
2022-06-13
Everest and Gilead Announce Positive Phase 3 Results of Breast Cancer Drug
2022-06-06
China Gives Conditional Approval to Pfizer’s Covid-19 Oral Antiviral
2022-02-14
Shanghai’s Everest Medicines Licenses COVID-19 Oral Antivirals from Singapore’s National Drug Discovery Platform
2022-01-17
China’s Everest Medicines Partners with Tech Giant Tencent to Develop Digital Healthcare Ecosystem
2021-07-16
Weekly in Asia 20190609-0615
2019-06-21
LATEST
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
Rice University Engineers Develop Miniature Brain Stimulator for Safer and Less-invasive Neuromodulation
2024-04-17
Breakthrough Screening Platform to Assess SARS-CoV-2 Mutations and Potential Treatments
2024-04-16
Join Us for the SABPA OC/LA 16th Annual Biomedical Forum!
2024-04-16
Sequencing Revolution Spotlights the Titans of NGS Innovation
2024-04-16
EVENT
2024-04-20
16th SABPA OC/LA Annual Biomedical Forum
The Beckman Center, 100 Academy, Irvine, CA, 92617
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top